1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Burkholderia Infections: new trials by email Literature Review of Burkholderia Infections trials Research Report on Burkholderia Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis Inhaled SNSP113, Inhaled Placebo - Lung Diseases, Pulmonary Disease | Phase 1 | Terminated | Synspira, Inc. | 32 | 2017-09-28 | 2018-05-25 |
| Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Patients Infected With Burkholderia Cepacia Complex TOBI - Cystic Fibrosis, Burkholderia Cepacia Infection | Phase 1 | Completed | Unity Health Toronto | 10 | 2014-09-01 | 2020-11-04 |
Cystic Fibrosis (2) · Infections (1) · Lung Diseases (1) · Mycobacterium Infections, Nontuberculous (1) · Pneumonia (1) · Respiratory Tract Diseases (1)
Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Digestive System Diseases (2) · Genetic Diseases, Inborn (2) · Gram-Negative Bacterial Infections (2) · Infant, Newborn, Diseases (2) · Pancreatic Diseases (2) · Actinomycetales Infections (1) · Gram-Positive Bacterial Infections (1) · Infections (1) · Lung Diseases (1) · Mycobacterium Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
Synspira, Inc. (1) · Unity Health Toronto (1)
Canada (1) · United Kingdom (1)
Maria Theresa Basco, MD, MPH (1) · Valerie Waters, MD (1)